Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Year Safety Study of Xalacom in Glaucoma/Ocular Hypertension
NCT00150267Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Pfizer. Started Feb 2002; status: completed.
02
Drugs
timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00150267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150267.